Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Largest single contract win

20 Jun 2024 07:00

RNS Number : 1385T
Concurrent Technologies PLC
20 June 2024
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

 

 

20 June 2024

 

 

Concurrent Technologies Plc

(the "Company" or the "Group")

 

Concurrent Technologies announces its largest single contract win

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, has secured its largest single contract to date for $4.46M to supply computer plug-in-cards to a major US Defence and Aerospace prime contractor.

 

The contract is for a large number of multiple standard products from the Company's refreshed product portfolio. The products are being used in a major Department of Defence programme to upgrade specific sensing equipment used in different aircraft types across multiple fleets.

 

Concurrent Technologies has been working closely with this customer for over two years on smaller defence capability upgrade programmes, demonstrating commitment to the relationship and developing trust and technical credibility. The Company was able to secure this win due to the strength of its relationship and growing track record with this US customer, along with its ability to deliver the latest technical features.

 

Miles Adcock, CEO of Concurrent Technologies, commented: "We had the right products available at the right time to satisfy the needs of our customer, enabling us to participate in this important upgrading of capability for the US Air Force, demonstrating the benefit of the Group's refreshed product development approach. Not only is it our largest ever contract, it's also our largest ever design-win. With an anticipated lifetime value in excess of $40M, this is a significant opportunity for the Company with sizeable purchase orders expected for the next seven to 10 years."

 

Enquiries:

 

Concurrent Technologies PlcMiles Adcock - CEO

Kim Garrod - CFO

 

 

+44 (0)1206 752626

Alma Strategic CommunicationsJosh Royston

Hannah Campbell

 

+44 (0)20 3405 0205

Cavendish Capital Markets Limited (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded Plug In Cards and Systems for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTSFMEEUELSEEM
Date   Source Headline
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update
14th Jan 20192:00 pmRNSLeave of Absence
8th Oct 20187:00 amRNSProduct Announcement
12th Sep 20187:00 amRNSInterim Results
6th Sep 20187:00 amRNSNotification of Interim Results
8th Jun 20187:00 amRNSProduct Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.